TRELA 100MG TAB 4s

Trela 100 mg tablets (4‑count pack), which contain Trelagliptin — a DPP‑4 inhibitor used for managing type 2 diabetes mellitus:

 What is Trela 100 mg?

• Active Ingredient: Trelagliptin succinate equivalent to 100 mg of Trelagliptin per tablet 

• Drug Class: Dipeptidyl peptidase‑4 (DPP‑4) inhibitor (same class as sitagliptin) 

• Indication: Adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes 

 Dosage & Administration

• Usual Dose: 100 mg once weekly (one tablet per week, not daily) 

• Can be taken with or without food, ideally on the same day each week for better consistency 

• Special Populations:

  • Moderate to severe renal impairment: higher blood levels; dose reduction (e.g. to 50 mg weekly) may be needed

  • Hepatic impairment: caution advised, with monitoring and possible dose adjustment

 Benefits

• Convenient once-weekly dosing, which may improve treatment adherence 

• Effective in reducing HbA1c, fasting glucose, and postprandial glucose levels 

• Low risk of hypoglycemia when used alone (increases insulin in response to glucose only)

• Compatible with other antidiabetic treatments like metformin, sulfonylureas, or insulin 

 Side Effects & Precautions

Common Side Effects:

• Nasopharyngitis or upper respiratory tract infection (e.g. cold symptoms)

• Headache

• Abdominal discomfort, diarrhea